You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PHENERGAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Phenergan patents expire, and what generic alternatives are available?

Phenergan is a drug marketed by Wyeth Ayerst, Norvium Bioscience, Delcor Asset Corp, and Ani Pharms. and is included in six NDAs.

The generic ingredient in PHENERGAN is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENERGAN?
  • What are the global sales for PHENERGAN?
  • What is Average Wholesale Price for PHENERGAN?
Drug patent expirations by year for PHENERGAN
Drug Prices for PHENERGAN

See drug prices for PHENERGAN

Drug Sales Revenue Trends for PHENERGAN

See drug sales revenues for PHENERGAN

Recent Clinical Trials for PHENERGAN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Colorado, DenverPhase 4
University of FloridaPhase 4
South Valley UniversityPhase 1

See all PHENERGAN clinical trials

US Patents and Regulatory Information for PHENERGAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst PHENERGAN promethazine hydrochloride INJECTABLE;INJECTION 008857-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Delcor Asset Corp PHENERGAN promethazine hydrochloride TABLET;ORAL 007935-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience PHENERGAN promethazine hydrochloride SUPPOSITORY;RECTAL 010926-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Delcor Asset Corp PHENERGAN promethazine hydrochloride TABLET;ORAL 007935-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.